Question Is there an association between empagliflozin and the risk of nonproliferative diabetic retinopathy (NPDR) and diabetic retinopathy (DR) progression in patients with type 2 diabetes (T2D)?
Findings In this cohort study, there was no association between empagliflozin and incident NPDR in patients with T2D who had no DR history; however, empagliflozin was associated with a decreased risk of DR progression in patients with T2D and history of NPDR.
Meaning The findings of this study suggest that empagliflozin use may reduce the risk of short-term DR progression in patients with T2D and history of NPDR.
https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2827448
2 Medical News 